Introduction
============

Stroke
------

Stroke is a leading cause of acquired adult long-term disability in the United States ([@B3]) and occurs when blood supply to the brain is compromised, leading to functional deficits that may affect activities of daily living (ADLs). Approximately 85% of patients who suffer and survive a new or recurrent stroke in the United States each year require rehabilitation ([@B66]). Six months post-stroke, nearly 50% of survivors have some residual motor deficits ([@B3]). By 2050, stroke burden on the United States economy will approach \$2.2 trillion ([@B3]). Despite advances in acute stroke care, the estimated direct and indirect costs of stroke continue to escalate and are disproportionally associated with long-term care and rehabilitation ([@B3]). Current standard of care seems insufficiently developed to treat long-term motor deficits, potentially further burdening patients as untreated motor impairment can lead to deconditioning and underutilization of the affected upper extremity (UE), a consequence deemed, learned non-use (LNU) ([@B51]).

Customary Care and the Opportunities for Improvement
----------------------------------------------------

Several rehabilitation techniques are traditionally used for stroke recovery including conventional physical-occupational-speech therapies, provided in acute care settings as well as newer motor therapies such as constraint-induced movement therapy (CIMT), robot-aided therapy, transcranial direct current stimulation (tDCS), transcranial magnetic stimulation (TMS), and virtual reality (VR) ([@B22]; [@B28]; [@B12]; [@B67],[@B68],[@B69]; [@B26]; [@B57]; [@B2]; [@B56]). Importantly, a much different level of evidence exists for CIMT and traditional therapies than experimental therapies such as tDCS and VR-based approaches. Existing pharmacological treatments, Botox injections for example, and traditional physical therapy methods primarily serve to treat symptoms associated with stroke ([@B3]) and may not focus on bringing about basic changes to the underlying impaired brain function associated with relevant post-stroke pathologies. Patients with UE motor impairment traditionally receive rehabilitation regimens that involve passive, repetitive movement of the impaired limb without directly linking brain activity to these movements ([@B10]). Whereas passive movement repetition can be an effective rehabilitation strategy, recovery can be slow, and suboptimal. In contrast, linking brain activity to movement is important for motor skill learning (e.g., walking, running, throwing, writing, etc.) and the formation of central to peripheral connections. Leveraging this innate and robust motor learning circuitry, harnessing brain plasticity ([@B59]), may be the next step toward improve patient outcomes.

Motor Recovery
--------------

Research suggests that motor recovery post-stroke, similar to motor learning, requires specific internal and external environmental conditions ([@B46]; [@B63]). For example, lesion load is a limiting factor as sufficient existing neural-architecture is needed for motor recovery to occur ([@B46]). Recovery likely manifests either by the return of function to surviving neural architecture, or via neural reorganization and neural network remapping of proximal (i.e., near-by) neural architecture ([@B13]; [@B20]). Perhaps such processes may even be related. If neuroplasticity in the motor system, though likely attenuated by age, is continuous ([@B13]) over the life course ([@B46]; [@B63]), long-studied learning theories such as Hebbian plasticity and classical conditioning might be better integrated in treatment designs to aid recovery of stroke impaired UE motor capacities ([@B46]; [@B48]). The incorporation of neurorehabilitation techniques has yielded operational clinical therapies and devices ([@B42], [@B43]; [@B37]; [@B44]; [@B11]; [@B53]; [@B46]; [@B24]; [@B67]; [@B63]). As a number of existing approaches suffer from issues of high cost, passive movement repetition, large equipment, personnel and time constraints it is crucial efforts are made to pursue more expedient and efficacious means of rehabilitation, improve our quality of care, and better serve our survivors.

Sensorimotor Rhythms
--------------------

Human brain rhythms associated with motor output, sensorimotor rhythms (SMRs), are recorded superficial to the motor and somatosensory cortical strip of the brain (electrode sites C3 and C4) and originate according to homuncular organization ([@B42]; [@B4]). At the motor cortical strip (generally, Brodmann areas 3--6), each brain hemisphere desynchronizes with imagined, attempted, and also preparation of movement. This phenomenon is known as event-related desynchronization (ERD). Specific frequency bands have been associated with specific aspects of event-related motor behaviors ([@B42], [@B43]; [@B11]; [@B53]; [@B58]; [@B68]). In normal effortful movement, Mu rhythms of the contralateral cortex are desynchronized and attenuated (ERD) as movements are planned and executed ([@B42]). This is followed by an increased presence of Beta rhythm ERD in the contralateral motor cortex which is associated with the later stages of motor command output and control ([@B44]). After the completion, or at the cessation of movement, the SMRs in Mu and Beta frequency bands synchronize (ERS). ERD and ERS were key elements in the development and use of early BCIs for the rehabilitation of motor functions ([@B42], [@B43]; [@B36]). The early designs confirmed that ERD or ERS in specific spatial areas and neural networks (e.g., thalamocortical networks, frontoparietal networks) associated with a task or triggered events can be utilized to control a device or output command ([@B42]; [@B37]).

Mu and Beta sensorimotor rhythms (SMRs) in human subjects are recorded exclusively over sensorimotor areas at frequencies of about 10--20 Hz ([@B42]; [@B4]). Two basic strategies in SMR-based control have been introduced for motor rehabilitation in stroke patients: motor imagery ([@B65]; [@B40]; [@B19]) and attempted movement-based approaches ([@B65]; [@B52]; [@B67],[@B68],[@B69]). Either approach utilizes essentially overlapping neural architecture to provide input signals (electrophysiological recordings by the EEG cap) to the BCI. The authors of this study designed the protocol to utilize attempted hand movements during the intervention according to the logic that a motor therapy intended to restore volitional motor function of the affected UE should utilize voluntary attempted movements of that impaired hand in a continuous effort to improve the participant's UE capacity and performance.

Brain--Computer Interface (BCI) and Electroencephalography for Assistive Design
-------------------------------------------------------------------------------

Noninvasive brain--computer interfaces (BCIs), which utilize ancillary adjuvant peripheral devices and electrical muscle stimulation, as well as invasive BCI approaches with electrodes implanted in the skull, have been introduced ([@B65]; [@B27]; [@B52], [@B53]; [@B31]; [@B11]) as contemporary intervention and rehabilitation techniques following neural disease or trauma, such as stroke. Devices similar to what was utilized in this research are controlled by input signals generated by scalp electroencephalographic (EEG) recordings from electrodes superficial to the sensorimotor cortices. EEG signals associated with various components of voluntary movement are identified and translated into a device command or specified output ([@B42], [@B43]; [@B11]; [@B53]; [@B64]), like activation of an FES pad ([@B58]; [@B67],[@B68]). BCIs can monitoring volitional modulation of electrical brain rhythms and execute an augmentative, facilitative, or rehabilitative command in the presence or absence of such signals.

Adjuvants
---------

In this study, EEG driven BCI was linked to tongue stimulation (TS) via a Tongue Display Unit (TDU) ([@B21]; [@B64]) (designed as a visual supplementation for any participant with visual impairments) and FES, which can act not only as therapeutic adjuvants but, when tied to intent-to-move brain signals, also provide users with multi-modal feedback as a form of monitoring and reward for producing relevant brain activity patterns (SMR modulation) during tasks. Adjuvant stimulation may not only aid execution of the motor plan by causing the contraction of the impaired UE musculature but may also help the user learn new movement strategies for the impaired extremity. Adjuvant-induced proprioceptive and general afferent inputs to the motor system complete the BCI design's replication of the native neurobiological closed-loop motor system. Such adjuvant-aided volitional movement may not only make a movement possible but also contribute ancillary components for motor learning. Rewards of tactile, kinesthetic feedback to the system and the visual revelation of a previously impaired appendage now voluntarily animated may prove powerful ([@B33]; [@B23]; [@B45]; [@B17]) reinforces.

Evidence
--------

Growing evidence from our lab ([@B67],[@B68],[@B69]; [@B57]) and other groups ([@B16]; [@B9]; [@B8]; [@B6]; [@B34]; [@B1]; [@B61]; [@B5]) suggest that noninvasive EEG-BCI-FES systems hold potential for facilitating recovery in the chronic phase after stroke by linking central nervous system (CNS) commands, or brain activity, with distal motor effectors (the manifestation of the motor plan via trained muscle synergies) of the peripheral nervous system (PNS). Integration of the aforementioned command with facilitated movements within strict reinforcement constraints (e.g., task accuracy: drop the cup, move the ball or not) might thereby better harness neuroplastic capacities leading to functional gains in recovery for individuals with stroke related hemiparesis. Previous studies suggest that change in the pattern of brain activity linked to attempted movements of the affected hand contributes to motor re-conditioning and induces brain plasticity or reorganization which, if properly directed and reinforced, should lead to improvement in a stereotyped motor function of interest ([@B8]; [@B6]; [@B34]; [@B61]). This is of special importance for patients in the chronic phase (generally \>6 months post stroke) of recovery who may have little to no residual function in the affected arm, in addition to learned compensatory motor strategies ([@B34]). Given that these participants have also likely exhausted other forms of intervention available to them through standard healthcare channels, it is imperative to explore novel intervention technologies that show promise in this population.

Overview of This Study
----------------------

It was hypothesized that (1) the EEG-BCI-FES intervention sessions would result in increased hemispheric desynchronization levels of Mu (8--12 Hz) rhythm and, or Beta (18--26 Hz) band signals over the ipsilesional motor cortices, as reflected by increased r-squared values (i.e., lower power in the impaired hand movement trials compared to rest), and (2) changes in functional connectivity (coherence) are greatest in the affected contralateral (ipsilesional) motor cortex and, over time, are associated with beneficial behavior and quality of life improvements as measured by objective and subjective measures of upper extremity motor function and activities of daily living. This interim analysis, of the larger ongoing prospective randomized crossover-controlled clinical trial, seeks to determine whether greater desynchronization of motor related SMRs in the ipsilesional hemisphere during attempted movements of the impaired hand are related to changes in behavior as a result of intervention.

Materials and Methods {#s1}
=====================

Subjects and Design
-------------------

### Ethics Statement

Participants were recruited from the greater Madison, WI, United States area as part of an on-going prospective randomized, cross-over controlled design stroke rehabilitation study investigating interventional BCI targeting UE motor function. This study is approved by the University of Wisconsin Health Sciences Institutional Review Board (Study ID 2015-0469); all subjects provided written informed consent upon enrollment. A CONSORT flow diagram is made available in [Supplementary Figure S1](#SM1){ref-type="supplementary-material"}.

### Recruitment and Enrollment

This on-going study, registered with [ClinicalTrials.gov](https://clinicaltrials.gov/) (study ID^[1](#fn01){ref-type="fn"}^ NCT02098265), employs an open call for participants with a wide range of (1) UE hemiparesis resulting from stroke, (2) time-since-stroke, (3) stroke type, (4) lesion location, (5) number of previous strokes, (6) and stroke severity. Subsequent to informed, written consent, stroke survivors were randomized by permuted-block design accounting specifically for gender, stroke chronicity, as well as severity of motor impairment as measured by the Action Research Arm Test (ARAT) ([@B25]) (*n* = 21, mean age = 61.6 years ± 15.3 years, 12 female, 13 right lateralized lesion, mean chronicity = 1127 days ± 1326.5 days, median chronicity 588 days, 11 with severe UE motor deficit, mean baseline ARAT score of impaired side = 26.6 ± 26.1). Chronicity is measured as time since stroke, in days, to baseline measurement day. Participant characteristics are displayed in [Table 1](#T1){ref-type="table"}. This interim analysis of the larger ongoing study seeks to elucidate the electrophysiological consequences and associations of BCI participation and the authors focus specifically on the behavioral (primary outcome) associations in another manuscript published in tandem with this effort ([@B47]).

###### 

Participant characteristic and ARAT score.

  Participants   Age (years)   Chronicity (days)   Severity   Clinical cause                       Baseline   Completion   Follow-up   ARAT
  -------------- ------------- ------------------- ---------- ------------------------------------ ---------- ------------ ----------- ------------
  1              47--51        160                 Severe     L-Lateral medulla                    3          2            7           --1 (4)
  2              49--53        490                 Severe     R-MCA stroke                         3          4            8           ^∗^1 (5)
  3              76--80        658                 Mild       Leg/periventricular white, MHR       57         57           57          0 (0)
  4              67--51        2723                Severe     R-PLIC putamen                       23         40           39          ^∗^17 (16)
  5              81--85        580                 Mild       Cerebellar vermis                    47         52           52          ^∗^5 (5)
  6              73--77        197                 Severe     R-Prefrontal, midfrontal, temporal   0          0            3           0 (3)
  7              62--66        101                 Mild       R-White matter                       56         57           57          ^∗^1 (1)
  8              40--44        2645                Severe     R-Frontal parietal                   7          7            7           0 (0)
  9              55--59        588                 Severe     R-MCA                                3          4            0           ^∗^1 (-3)
  10             45--49        452                 Severe     L-Hemorrhagic stroke                 0          2            0           ^∗^2 (0)
  11             30--34        494                 Mild       L-ICA                                57         57           57          0 (0)
  12             60--64        44                  Mild       L-PCA                                57         57           57          0 (0)
  13             57--61        849                 Mild       L-MCA                                57         57           57          0 (0)
  14             44--48        3017                Severe     R-MCA/R-FI                           3          4            5           ^∗^1 (2)
  15             69--73        790                 Severe     R-MCA/R-TP                           3          0            3           --3 (0)
  16             78--82        631                 Mild       R-Occipital                          57         57           57          0 (0)
  17             75--79        5125                Severe     R-MCA/ACA                            9          11           10          ^∗^2 (1)
  18             42--46        177                 Mild       L-MCA                                57         57           57          0 (0)
  19             62--66        392                 Severe     R-Frontal hematoma                   3          5            16          ^∗^2 (13)
  20             55--59        2767                Mild       R-VAOA, subarachnoid hemorrhage      57         57           57          0 (0)
  21             69--73        783                 Severe     R-MCA                                0          0            0           0 (0)
  \(A\) Mean     61.6          1127                                                                26.6       27.9         28.9        1.3 (2.2)
  Median         61.9          588                                                                 9          11           16          0 (0)
  SD             15            1327                                                                26.4       26.6         25.9        3.9 (4.5)
  \(B\) Mean     61.1          1289                                                                11.4       13.4         14.8        2 (3.4)
  Median         64            584                                                                 3          4            7           1 (1.5)
  SD             13.5          1497                                                                18         20.2         19.6        4.7 (5.2)

ARAT, Action Research Arm Test; MCA, middle cerebral artery; ICA, internal carotid artery; PCA, posterior cerebral artery; FI, frontoparietal infarct; TP, temporal frontal-parietal; ACA, anterior cerebral artery; MHR, motor hand region; VAOA, vertebral artery origin aneurysm; L, left; R, right; ARAT change, completion-baseline (follow-up baseline). (A) Indicates descriptive statistics for all (

n

= 21) participants; (B) indicates descriptive statistics for (

n

= 14) participants able to achieve ARAT improvements (ceilings removed). Positive change in outcome measure at competition of BCI intervention denoted by '

∗

'.

### Inclusion--Exclusion Criteria

Participants age 18 years or older with persistent UE motor impairment resulting from stroke and no other known neurologic (cognitive, expressive), psychiatric (affect), or developmental disabilities were included. Exclusion criteria were: allergy to electrode gel, surgical tape, metals, concurrent treatment for infectious disease, apparent lesions or inflammation of the oral cavity, pregnancy or intention to become pregnant during the course of the study, or any contraindication for magnetic resonance imaging (MRI). Subjects from the greater study cohort were excluded from the presented analyses if they (1) failed to complete at least 9 of 15, two-hour BCI intervention sessions occurring at least twice each week, (2) failed to complete all four MRI and behavioral testing sessions occurring in the intervention phase ([Figure 1](#F1){ref-type="fig"}).

![Study design. The time-points at which neuroimaging data were collected are represented by, T1, control baseline; T2, control middle; T3, control completion; T4, intervention baseline; T5, mid-intervention; T6, completion of intervention; T7, 1-month post-intervention. While the crossover control group (DTG) completed visits T1 through T7, the immediate therapy (ITG) group completed only visits T4 through T7. EEG-BCI-FES intervention is only administered during the BCI Therapy Phase (green), from baseline (T4) to completion (T6), and EEG recordings are neither acquired between T1 and T4, nor between T6 and T7 during which only MRI and behavioral testing batteries are administered. EEG data were only collected during the intervention phase.](fnins-13-00053-g001){#F1}

### Randomization and Study Schema

Participants, when assigned to the intervention phase, have at least 9 and up to 15 EEG-BCI-FES intervention sessions (two-to-three sessions/week) wherein they receive EEG-BCI-FES intervention lasting up to 2 h for a potential total dosing of 30 h of EEG-BCI-FES intervention. Along with the EEG-BCI-FES intervention sessions, subjects also receive fMRI and behavioral testing at four time points: prior to the first EEG-BCI-FES intervention session (baseline), after the first few weeks of intervention (midpoint), following the final intervention session (endpoint), and again 1 month after the endpoint assessment (follow-up). Subjects assigned to the delayed intervention group (DTG) are encouraged to continue with their normal and customary care while in the delay period. While in the delay period, participant EEG data are not recorded and participants are instructed not to use a BCI device. During this time, there are three assessment visits consisting of MRI and behavioral testing which are matched in sequence and duration to those conducted in the BCI intervention period as demonstrated in [Figure 1](#F1){ref-type="fig"}. After completion of the delay period, these participants cross over into the intervention phase and are assessed in accordance with previously described methods. All data and time points analyzed and presented herein were recorded during the BCI intervention period only, for all participants. EEG data were only collected during the intervention phase.

The BCI System
--------------

The BCI system and intervention sequence were consistent with those previously described ([@B64]; [@B58], [@B57]; [@B67],[@B68],[@B69]) using BCI2000 software ([@B52]) version 2 with in-house modifications for input from a 16-channel EEG cap and amplifier (Guger Technologies) and integration with the ball and target gaming visual display as well as tongue stimulation (TDU 01.30 Wicab Inc.) ([@B21]) and functional electrical stimulation (FES) (LG-7500, LGMedSupply; Arduino 1.0.4). FES of the UE was delivered through a pair of 2" × 2" square electrodes, commercially available stimulus isolator units, which ensure clean, opto-electrical isolation, placed securely on the affected forearm using highly conductive Electrolyte Spray and produced by the LG-7500 Digital Muscle Stimulator LGMedSupply, Cherry Hill, NJ, United States). The electrodes were placed to facilitate either a grasping motion (finger flexion), or finger extension according to participant preference. Specific placement sites were superficial to flexor digitorum superficialis to facilitate hand and finger flexion, or superficial to extensor digitorum communis to facilitate hand and finger extension. The natural absence of a flexor digitorum superficialis tendon to the fifth digit in some individuals was not considered in this study design. Stimulation was controlled through the PC using an Arduino Uno R3 (Adafruit Industries, New York, NY, United States) and a simple Reed-Relay circuit, with the amplitude set to elicit observable muscle activation (e.g., finger grasping) without pain. The pulse rate of the stimulation was set to 60 Hz in order to produce tetanic contraction of the muscle and the pulse width was set to 150 μs. The input signal, initially set to zero, was adjusted by steps of 0.5 mA, unless the stimulation became uncomfortable for the subject. The device was never set to deliver an output greater than 5 mA. In previous publications, the TDU ([@B21]) has been described and its use in a BCI paradigm detailed ([@B64]). This BCI system uses the same TDU stimulation parameters as were reported previously ([@B64]).

Brief Overview of the Procedure (EEG Tasks)
-------------------------------------------

### EEG-BCI-FES Intervention

Subjects went through intervention sessions on separate days. The number of EEG-BCI-FES intervention sessions varied across subjects with a mean of 13.8 ± 1.3. Each EEG-BCI-FES intervention session consisted of multiple runs of the 'Cursor Task' (mean of 31.3 ± 10.5 runs per session), about 1/3rd of which included only visual feedback, and roughly two thirds of which were comprised of BCI facilitated functional electric stimulation of the impaired hand and lingual electrotactile stimulation through a tongue display unit (TDU) ([@B21]; [@B64]) ([Figure 2](#F2){ref-type="fig"}). The EEG-BCI-FES device was driven by spectral power recordings from contralateral (to the hand active in the grasping task) EEG electrodes during cued attempted grasping movements of the hand which was designed to modulate the horizontal movement of a cursor ([@B53]) in a computer display space as well as facilitate concurrent functional electrical stimulation of the participant's impaired UE (should the target appear on the side corresponding to their stroke-impaired hand). BCI classifier inputs were therefore at C3 and C4, respectively in Mu (8--12Hz) and Beta (18--26Hz) frequency bands in this design. Each EEG-BCI-FES (closed-loop) intervention session was preceded by an open-loop pre-therapy screening phase and followed by an open-loop post-therapy screening phase ([Figure 2](#F2){ref-type="fig"}). The successive order of intervention procedure was as follows: visual only, visual + FES, visual + FES + tongue feedback. All intervention sessions included in this analysis contained a similar distribution of these conditions across all participants.

![BCI intervention block design. **(1)** Pre-screening (two actual movement trials, two imagined movement trials). **(2)** Cursor task (≥10 trials with visual-only feedback). **(3)** Cursor task with adjuvant stimuli (≥10 trials with adjuvant stimuli). **(4)** Post-screening (two imagined movement trials, two actual movement trials).](fnins-13-00053-g002){#F2}

### Familiarization With BCI Device and Procedures

The first BCI session was focused on assisting the participant to comprehend and engage the BCI device and protocol. Stroke survivors often present with a myriad of cognitive, affective, and physical impairments ([@B35]) and out of respect for individual participant needs and abilities, the researchers intended to provide at outset an opportunity for a generous orientation rather than rigorous acquisition. During this preliminary session, the EEG cap ([Figure 3](#F3){ref-type="fig"}), FES device, and TDU device were faithfully administered as described previously ([@B64]). Participants were verbally instructed before each session, and as needed, to aim for successful completion of BCI tasks and for each attempted movement to be performed to the participant's autonomously elected level of comfort and ability. There were no participants in this study whom were unable to comprehend or participate successfully in the intervention protocol as a result of any associated cognitive or aphasic impairments associated with their stroke. The study design requires at least 10 runs for each closed-loop condition, per session; however, enforcement discretion was encouraged until a participant demonstrated task comprehension during the first BCI intervention session.

![BCI cap array. Electrode array and cap arrangement for all *n* = 21 participants. Control signals generated at C3 and C4 electrodes for right and left hand movement trials, respectively. Ear clip always placed on the right ear.](fnins-13-00053-g003){#F3}

Description of the Raw EEG Data
-------------------------------

EEG data were recorded using a 16-ch bioamplifier (g.USBamp; G.TEC Medical Engineering GmbH, Austria) from 16 active electrodes using a g.GAMMA cap (F5, C5, FC1, C3, P5, F6, C6, P6, Pz, P4, P3, FC2, Cz, CP2, C4, CP1) ([Figure 3](#F3){ref-type="fig"}) according to 10-20 EEG electrode placement system with a right ear-lobe reference in a BCI2000 system environment ([@B52]). The frequency bandwidth of the recorded signals was 0.1--100 Hz, with an additional notch-filter applied at 60 Hz. The sampling rate was 256 Hz. During each of the screening phases (pre- and post-therapy) EEG data were collected in four separate runs. Each screening EEG data file contained 15 trials for rest, left hand and right hand movements (i.e., five trials for each of the three conditions), separated by an interstimulus interval of 1.5--2 s. The order of trials in a run was random. Each of the trials had a duration of 4 s. The first two runs of the pre-therapy screening phase and the last two runs of the post-therapy screening phase incorporated cued "attempted" hand movements. The last two runs of the pre-therapy screening phase and the first two runs of the post-therapy screening phase incorporated cued "imaginary" hand movements.

Description of the EEG Data Analysis
------------------------------------

The raw EEG data files were loaded into Fieldtrip (a MATLAB-based toolbox for advanced neurophysiological data analyses), and fully processed using tools incorporated in this toolbox ([@B38]) and MATLAB environment^[2](#fn02){ref-type="fn"}^. The main processing steps for the EEG data collected during screening phases were as follows:

\(1\) Digital filtering with a high-pass filter cutoff of 4 Hz, and a low-pass filter cutoff of 30 Hz. (2) Extraction and grouping of trials according to condition (rest, left hand movement, right hand movement), movement type (attempted, imaginary), and the screening phase (pre, post). This resulted in 10 trials for each of condition/movement/screening phase combinations. (3) Identification (variance based: thresholds set to 10 and 250 μV^2^ for low and high variance signals, respectively) and repair of bad (noisy) channels (spline interpolation), followed by the removal of three trials showing the highest variance ([@B60]; [@B32]). The channel was identified as bad (noisy, poor connection, etc.) if the variance was \<10 or \>250 μV^2^ in more than three trials ([@B60]; [@B32]). The units of the variance were those of the data squared: as the EEG data units were in micro Volts, the variance units were squared micro Volts. If more than four channels were identified as bad, the data for that session were removed from further analysis (i.e., 20.4% of data were discarded by not meeting the defined criteria). At session level, this step resulted in 28 s of EEG data (7 trials × 4 s) for each condition/movement/screening phase combination set. (4) An average-reference montage was applied to the data (i.e., re-referencing from the original monopolar recordings). (5) Spectral analyses with Fourier transforms computed using a multi-taper method ([@B60]; [@B32]) at a 0.25 Hz resolution: this finally resulted in estimates of absolute spectral power sampled for every 1 Hz bin during the interval of 4--30 Hz, and cross-spectral density. The trial length was 4 s and the resolution of Fourier Transforms was 1/4 = 0.25 Hz. (6) Coherence estimation was calculated between all pairs of channels (120 pairs from 16 available scalp channels) at every 1 Hz frequency bin of the mentioned interval. Coherence was calculated as the absolute value of the ratio of the cross-spectrum to the square-root of the product of the two auto-spectra (as applied in Fieldtrip software). (7) Calculation of signed r-squared (r-squared: coefficient of determination) values from the absolute power estimates between left or right hand movements and rest trials, and between the two movement conditions (left vs. right). The r-squared values were signed in a such way that a large negative number (-) would mean larger "desynchronization" of the rhythm (Mu or Beta) ([@B42], [@B43]; [@B37]; [@B44]). (8) Calculation of change (POST--PRE) in signed r-squared values: the following formula was used: -(POST--PRE), so one would obtain positive numbers for "increases" in desynchronization. This was done for easier interpretation of the associations of r-squared changes with behavior changes as the result of EEG-BCI-FES intervention. Here the "flipping" of values (in order to assess the "impaired hand," L or R) was applied to the impaired R-hand scores to put them together with scores from the impaired L-hand subjects. (9) Calculation of the laterality index (LI) for averaged coherence values (i.e., average coherence of each site with all others), used to evaluate shifts in coherence, as: (C3 - C4)/(C3 + C4). (10) Change (POST--PRE) in coherence LI values: LI as a number becomes more positive if there is a shift toward Left, and more negative if there is a shift toward Right (as the result of intervention). Therefore, for POST--PRE change in LI, the impaired L-hand values were multiplied with (-1) and the impaired R-hand values remained unchanged, as they were originally calculated. This way, the "expected change" is positive and the associations with behavioral changes can be more seasily interpreted.

Statistics
----------

The independent variables were the signed r-squared values and the coherence estimates. At individual subject level, the data consisted of average estimates per each session for condition/movement/screening phase combination sets, and at group level the estimates consisted of grand averages over sessions of each individual subject data in the group (pre- and post-therapy scores averaged separately across sessions). Non-parametric statistical tests were run by calculating Monte-Carlo estimates of the significance probabilities and critical values from the permutation distribution ([@B29]), followed by correction for multiple comparisons using false discovery rate (FDR) when no prior hypothesis was available. The *priori* hypotheses of expected changes in the r-squared values and coherence as the result of intervention time at C3 and C4 sites were tested using paired *t*-tests in MATLAB. Associations between the r-squared changes and the total number of intervention runs as well as behavioral changes (e.g., ARAT scores) were assessed using Pearson's and Spearman's correlation, respectively. Finally, the associations between the signed r-squared values with behavioral scores from several tests at baseline were assessed using Spearman's or Pearson's correlation coefficients, as appropriate. Thresholds for significance and trend toward significance were set *a priori* at *p* ≤ 0.05 and 0.05 \< *p* \< 0.1, respectively, for all statistical analyses.

Description of the Behavioral Outcome Measures
----------------------------------------------

The primary outcome measure was the ARAT. The ARAT is a 57-point test designed to assess specific changes in upper limb function with sub-components for grasp, grip, pinch, and gross motor movement ([@B18]). The secondary measures include: The Stroke-Impact Scale (SIS), widely used to measure quality of life in stroke survivors that consists of 8 dimensions and a composite disability score ([@B62]). The SIS is a 59-item patient-reported outcome measure, covering eight domains; strength (4 items), hand function (5 items), mobility (9 items), ADLs (10 items), memory (7 items), communication (7 items), emotion (9 items), and handicap (8 items); the domains are scored on a metric of 0--100, with higher scores indicating better self-reported health ([@B62]). The National Institutes of Health Stroke Scale (NIHSS) is a tool used by healthcare providers to objectively quantify impairments caused by a stroke ([@B39]). The NIHSS is composed of 11 items, each of which scores a specific ability between zero and four with higher scores indicating increased impairment ([@B39]). The Barthel scale, or Barthel ADL index, is a scale used to measure performance in ADLs ([@B54]). It utilizes ten variables describing ADL and mobility. The ten variables addressed in the Barthel scale are: presence or absence of fecal incontinence, presence or absence of urinary incontinence, help needed with grooming, help needed with toilet use, help needed with feeding, help needed with transfers (e.g., from chair to bed), help needed with walking, help needed with dressing, help needed with climbing stairs, help needed with bathing. This scale yields a score of 0--100 with higher scores indicating improved performance ([@B54]). Gross grasp grip strength was measured using a dynamometer ([@B36]). The Nine-Hole Peg Test (9-HPT) is a brief, standardized, quantitative test of UE function ([@B30]). The score for the 9-HPT is an average of the two trials ([@B30]). Mini-Mental State Examination (MMSE) is scored out of 30 ([@B41]). An MMSE score of 27--30 is generally associated with normal memory: a score 10--26 could indicate mild to moderate dementia, and a score less than 10 suggests severe dementia ([@B41]). The Center for Epidemiologic Studies-Depression (CES-D) scale is one of the most frequently used self-report measures of depressive experiences ([@B55]). The CES-D contains 20 items that are summed so that scores have a potential range from 0 to 60, with higher scores indicating greater frequency of depressive experiences ([@B55]).

Analyses of Outcome Measures
----------------------------

Primary analysis was a paired-sample *t*-test to evaluate the statistical significance of ARAT and secondary outcome measure changes (i.e., SIS, NIHSS, Barthel scale, grip strength, 9-HPT, MMSE, and CES-D) between baseline, completion, and follow-up scores ([Table 2](#T2){ref-type="table"}).

###### 

Summary of mean outcome measure scores for baseline, completion, and follow-up of the BCI training conditions.

  Outcome measures                                                          Baseline score    Completion score   Follow-up score   Change score   *p-*Value
  ------------------------------------------------------------------------- ----------------- ------------------ ----------------- -------------- ---------------------
  Stroke Impact Scale (SIS) (Max = 100) [SIS]{.smallcaps}~Hand\ function~   33.6 (15) 38.1    39 (25) 37.5       39.8 (25) 39.7    5.4 (62)       0.482 ^∗^(0.050)
  SIS~recovery~                                                             50.1 (50) 23.7    53.4 (60) 24.9     54.6 (60) 21.8    3.3 (4.5)      0.509 (0.216)
  **NIH Stroke Scale/Score (NIHSS)** (Max = 4)                              3.8 (3) 3.5       3.8 (2.5) 3.1      3.7 (2.5) 3.1     0 (-0.1)       1.0 (0.749)
  **Barthel Index-Total** (Max = 100)                                       91.4 (100) 14     92 (97) 13.9       92.8 (100) 14.8   0.6 (1.3)      0.431 (0.167)
  **Grip strength** (lbs)                                                   18.8 (8.3) 21.5   22.6 (14.3) 23.5   20.5 (5) 24.6     3.8 (1.7)      ^∗^0.046 (0.246)
  **9-HPT** (seconds)                                                       17.7 (0) 22.8     15 (0) 19.1        14.4 (0) 20.3     --2.5 (-3.2)   0.083 (0.054)
  **MMSE** (Max = 30)                                                       27.2 (29) 3.8     27.8 (29) 2.7      28.3 (29) 2.7     0.6 (1)        0.467 (0.494)
  **CES-D** (Max = 60)                                                      7.6 (7.5) 5.8     7.8 (3) 9.9        5.6 (3) 5.9       0.2 (-2)       0.802 (0.096)
  **Action Research Arm Test (ARAT)** ARAT~Total~ (Max = 57)                16.9 (9) 23       18.3 (11) 23.4     21.4 (16) 23.4    1.3 (4.3)      ^∗^0.046 ^∗^(0.020)
  ARAT~Grasp~ (Max = 18)                                                    22 (3) 5.1        2.9 (5) 5.3        3.6 (6) 6.3       0.7 (01.5)     0.106 (0.163)
  ARAT~Grip~ (Max = 12)                                                     2.9 (2) 4.7       2.9 (3) 4.8        3.8 (4) 4.6       0.1 (0.9)      0.582 ^∗^(0.025)
  ARAT~Pinch~ (Max = 18)                                                    4.5 (1) 7.3       4.9. (0) 7.9       5.1 (4) 7.7       0.4 (0.6)      0.289 (0.106)
  ARAT~Gross~ (Max = 9)                                                     3.4 (5) 2.7       3.4 (6) 3          3.6 (6) 3         0 (0.3)        1.000 (0.453)

Measures are reported as mean (median) ± SD. Change score and

p-

value are reported as mean scores change between baseline and completion (mean scores change between baseline and follow-pp). ARAT scores are reported as mean scores change with ceilings removed.

∗

p

\< 0.05,

∗∗

p

\< 0.01,

∗∗∗

p

\< 0.001.

Results
=======

Results of Outcome Measures
---------------------------

Of the 21 participants who completed the study and met the aforementioned criteria, 14 participants had room for improvement in the primary outcome measure, ARAT (ARAT~total~), of which nine (64%) realized improved scores after intervention, both at immediate completion and 1 month after completion. Participant characteristics are summarized in [Table 1](#T1){ref-type="table"} and group outcome measures are further described in [Table 2](#T2){ref-type="table"}. All participant assessments at each time point were averaged to give a metric of cohort motor function change at the group level. Secondary measures were similarly group averaged to determine cohort measure changes as a result of time in intervention as well as at the 1 month follow-up ([Table 2](#T2){ref-type="table"}). The primary analysis showed significant change in baseline scores and completion scores ([Figure 1](#F1){ref-type="fig"}: T4, T6) in the primary outcome measure (ARAT) (*p* = 0.046), and change at follow-up (*p* = 0.020) ([Figure 1](#F1){ref-type="fig"}: T7), change in Grip Strength was found to be significant by completion of intervention (*p* = 0.046). This particular finding did not persist at the 1-month follow-up time point. Statistical significance was observed in the baseline to follow-up score analyses ([Figure 1](#F1){ref-type="fig"}: T4 to T7) not only for the primary outcome measure but also in secondary outcome measures of hand function (i.e., SIS Hand Function *p* = 0.05) ([Table 2](#T2){ref-type="table"}). All statistically significant findings were observed in measures of hand function. Additionally, the secondary analyses presented no significant results.

### EEG Measures

Results reported below in Section "R-Squared" echoed in the graph in [Figure 4](#F4){ref-type="fig"}, compared the signed r-squared values for the impaired hand separately from the non-impaired hand. The signed r-squared values from the Right-hand impaired participants at C3 (i.e., the ipsilesional motor site) were "pooled together" with the signed r-squared values from the Left-hand impaired participants at C4 (i.e., the ipsilesional motor site) consistent with methods described previously. [Figure 4](#F4){ref-type="fig"}--[8](#F8){ref-type="fig"} display topoplots of group level averages of signed r-squared values and coherence values and do not use flipped-maps. Therefore, the maps for the left hand movements represent "an average" of these measures from impaired hand movements (as the majority of participants in this group were left-hand impaired) and non-impaired left hand movements (minority of subjects). In the same fashion, the maps for the right hand movements represent an average of these measures from impaired hand movements (minority of participants in this group were right-hand impaired) and non-impaired right hand movements (majority of subjects). In essence, the authors didn't flip the maps that are displayed in the figures.

![Topographical plots (topoplots) of grand averages for Mu rhythm (8--12 Hz) signed r-squared values at group level (*n* = 21). The bar plot shows the group means for the Mu rhythm signed r-squared values from the impaired hand attempted movement trials (vs. rest) at ipsilesional electrode site. Asterisk denotes statistical significance from a one-tailed paired *t*-test (*p* \< 0.05). Error bars denote standard error of the mean. The majority of participants were left hand impaired. Prescreening, open-looped training (PRE) and open-looped post screening BCI training (POST) runs (color bar: \[--0.2 = blue -- 0.2 = red\]). The majority of participants had a right lateralized lesion.](fnins-13-00053-g004){#F4}

![Topoplots of grand averages for signed r-squared values at group level (*n* = 21) for attempted movements. In the top two rows of topoplots, a larger negative value (blue) denotes stronger desynchronization (rest vs. left or right hand actual movement); in the bottom row of topoplots a larger positive value (red) denotes desynchronization (left vs. right hand actual movements). The mentioned distinction reflects the way in which the signed r-squared values were calculated in a rest vs. left/or right comparison, and in a left vs. right comparison. Prescreening, open-looped training (PRE) and open-looped post screening BCI training (POST) runs (color bar: \[--0.2 = blue -- 0.2 = red\]). The majority of participants had a right lateralized lesion.](fnins-13-00053-g005){#F5}

![Topoplots of grand averaged coherence values at group level (*n* = 21) for Mu (8--12 Hz) and Beta (18--26 Hz) bands during attempted movement trials. Prescreening, open-looped training (PRE) and open-looped post screening BCI training (POST) runs (color bar: \[0 = blue -- 0.5 = red\]). The majority of participants had a right lateralized lesion.](fnins-13-00053-g006){#F6}

![Topoplots of grand averages for signed r-squared values at group level (*n* = 21) for imaginary movements. Prescreening, open-looped training (PRE) and open-looped post screening BCI training (POST) runs (color bar: \[0 = blue -- 0.5 = red\]). The majority of participants had a right lateralized lesion.](fnins-13-00053-g007){#F7}

![Topoplots of grand averaged coherence values at group level (*n* = 21) for Mu (8--12 Hz) and Beta (18--26 Hz) bands during imaginary movement trials. Prescreening, open-looped training (PRE) and open-looped post screening BCI training (POST) runs (color bar: \[0 = blue -- 0.5 = red\]). The majority of participants had a right lateralized lesion.](fnins-13-00053-g008){#F8}

EEG Results
-----------

### R-Squared

The signed r-squared value (at the ipsilesional C4 or C3 sites) for the Mu (8--12 Hz) rhythm significantly decreased in the post-therapy stage compared to the pre-therapy stage \[one-tailed paired *t*-test: *t*(20) = 1.85; *p* = 0.039; meanPRE = -0.142; meanPOST = -0.161\], while the subject attempted movements of the impaired hand ([Figure 4](#F4){ref-type="fig"}). This suggests that as the result of the intervention sessions, the "desynchronization" of the Mu rhythm signals significantly increases post-therapy at the ipsilesional motor site. The bar graph displays the significant difference in the group mean r-squared values. The signed r-squared values of the Mu band signals decreased also post-therapy at the contralesional motor site during attempted movements of the impaired hand, but these differences did not reach significance \[one-tailed paired *t*-test: *t*(20) = 1.24; *p* = 0.114; meanPRE = -0.131; meanPOST = -0.145\]. [Figure 5](#F5){ref-type="fig"} shows topographies of group-level grand averaged r-squared values obtained from data of 21 participants. Topoplots for both Mu and Beta bands are shown. While the presented results only describe changes in the Mu band, statistics from beta band did not reach significance. The Mu band and Beta band signals were both used for BCI control.

### LI

Laterality index (LI) values, calculated from coherence estimates at C3 and C4 sites from Beta band (18--26 Hz) signals, decreased in post-therapy stage compared to the pre-therapy stage \[one-tailed paired *t*-test: *t*(20) = 0.983, *p* = 0.168; meanPRE = 0.017; meanPOST = 0.009\] while the subjects attempted movements of the impaired hand, although this change did not achieve statistical significance ([Figure 6](#F6){ref-type="fig"}). This suggests that as a result of the intervention sessions, coherence in the affected motor site compared to the contralesional site showed a statistically insignificant increase at group level. [Figure 6](#F6){ref-type="fig"} shows topographies of group-level grand averaged coherence values from data of 21 subjects. The value entered in each electrode site of the mentioned topographies represents the average coherence of that site with all others.

### Imaginary Movement

Although no significant results were obtained from the analyses of data from imaginary movement trials, the topographical maps of r-squared and coherence values showed meaningful spatial distributions ([Figure 7](#F7){ref-type="fig"}, [8](#F8){ref-type="fig"}). [Figure 7](#F7){ref-type="fig"}, [8](#F8){ref-type="fig"} show topographical maps (topoplots) of grand averages for signed r-squared values at group level (*n* = 21) and topoplots of grand averaged coherence values at group level for Mu (8--12 Hz) rhythm and Beta (18--26 Hz) band during imaginary movement trials, respectively. As the protocol was designed to train and reward attempted movements, it is possible participants were not sufficiently able to master imagined movement related SMR modulation.

### Amount of Intervention: Number of Runs

The change in r-squared values (Beta band) in the ipsilesional hemisphere motor site during impaired hand attempted movements, following the intervention, showed a significant correlation with the total number of cursor trials (i.e., amount of BCI practice) runs \[*r*(20) = 0.393; *p* = 0.043\] ([Figure 9](#F9){ref-type="fig"}). Item number eight in Section "Description of the EEG Data Analysis" clarifies that for the calculation of change (POST--PRE) in signed r-squared values the following formula was used: -(POST--PRE), so one would again obtain positive numbers for "increases" in desynchronization. This was done for easier interpretation of the associations of r-squared changes with behavior changes as the result of EEG-BCI-FES intervention and in accord with the previously described methods. In essence, the positive correlation suggests that a greater amount of BCI practice relates to "greater" ERD.

![Association between the change in r-squared values (Beta band, 18--26 Hz) as the result of BCI training with the total number of cursor trial (i.e., intervention) runs \[*r*(20) = 0.393; *p* = 0.043\].](fnins-13-00053-g009){#F9}

### Influences on Primary Outcome Measure

In addition, the change in r-squared values (Mu rhythm) in the ipsilesional hemisphere motor site during impaired hand attempted movements, as the result of EEG-BCI-FES intervention, showed a positive, non-statistically significant correlation with the change in ARAT scores (obtained post-therapy in comparison to baseline) \[ρ(20) = 0.30; *p* = 0.098\] ([Figure 10](#F10){ref-type="fig"}).

![Association between the change in r-squared values (Mu rhythm, 8--12 Hz) as the result of BCI training with the change in ARAT scores (obtained post-intervention in comparison to baseline) \[ρ(20) = 0.30; *p* = 0.098\].](fnins-13-00053-g010){#F10}

### Influences of Stroke and ERD on Baseline Behavioral Measures of Function and Capacity

Finally, to test some of the fundamental assumptions of the study design and BCI device (that diminished SMR desynchronization is related to the post-stroke impairment of simple motor outputs), signed Mu and Beta r-squared values for the impaired hand attempted at baseline (i.e., first intervention session) were compared to measures of behavior (SIS, ARAT, Grip Strength), and measures of stroke-related impairments to functional capacities (NIHSS, Barthel Index) at baseline ([Table 3](#T3){ref-type="table"}). A few measures of behavior (Grip Strength, SIS) and independence, capacity to perform ADLs (Barthel Index, NIHSS), correlated significantly in the anticipated direction ([Table 3](#T3){ref-type="table"}). Relevant statistical significance tests were chosen for normal and non-normal distributions, respectively. These results suggest that SMR desynchronization may represent a fundamental neuromechanical component of motor capacity as well as motor learning and, therefore, any subsequent motor recovery potential.

###### 

Summary Pearson's r and Spearman's ρ correlates of baseline outcome measures and EEG-based signed r-squared scores (*n* = 21).

  Variables                    Pre-screening MU          Pre-screening BETA
  ---------------------------- ------------------------- -------------------------
  Baseline SIS hand function   ρ = -0.449, *p* = 0.041   ρ = -0.408, *p* = 0.066
  Baseline SIS recovery        ρ = -0.237, *p* = 0.301   ρ = -0.384, *p* = 0.085
  Baseline ARAT total          ρ = -0.367, *p* = 0.102   ρ = -0.405, *p* = 0.068
  Baseline Barthel Index       ρ = -0.292, *p* = 0.199   ρ = -0.573, *p* = 0.007
  Baseline grip strength       r = -0.369, *p* = 0.10    r = -0.437, *p* = 0.047
  Baseline NIHSS               ρ = 0.244, *p* = 0.28     ρ = 0.473, *p* = 0.03

Pearson's r was used for grip strength and Spearman's ρ was used for all other variables (two-tailed tests).

Adverse Events
--------------

No adverse events were reported during or after participation in the research experiment.

Discussion
==========

EEG Measure and Behavior Measure Fidelity
-----------------------------------------

The findings that motor cortex EEG measures during attempted movements of the impaired hand (more specifically, r-squared values reflecting desynchronization levels of Mu rhythm and Beta band signals at key motor cortical sites) are positively correlated with behavioral changes and seem to offer a measurable link between electrophysiology and behavior is in line with the hypotheses set forth in this analysis. More importantly, the significant group level changes in r-squared values post-therapy compared to pre-therapy suggest an effect of the applied EEG-BCI-FES intervention protocol which may be beneficial for motor recovery, though data are currently inconclusive. As stated in Section "Amount of Intervention: Number of Runs," the amount of BCI practice was positively correlated with Beta band ERD of the ipsilesional motor cortex. Thus, it may be possible to conceive that, following adequate amounts of training; electrophysiological measures of connectivity such as coherence may allow additional insights into the potentials and mechanisms of functional change to the neuromuscular and neuromechanical coupling of effortful motor movement.

EEG Utility in Stroke Rehabilitation
------------------------------------

A strength of this design and analyses for evaluation of objective physiological or functional changes as the result of the EEG-BCI-FES intervention is that the EEG-based measures extracted and compared were obtained immediately before, and immediately following each BCI intervention session (e.g., EEG-BCI-FES based rehabilitative intervention), at the pre an post screening periods ([Figure 2](#F2){ref-type="fig"}). By comparing the EEG-based measure (i.e., r-squared, coherence) changes at post- to pre-intervention session, this allowed a more controlled evaluation of the specific effects of EEG-BCI-FES intervention. In addition, because the EEG signals are continuously recorded as part of the procedure, EEG-based measures can be obtained with no additional cost at any desired time (restricted only by the short interval required to extract reliable individual measure scores from spectral analyses of the signals). Furthermore, the study design allowed extraction and comparison of spectral estimates separately from attempted actual, as well as imaginary, hand movements. The current study did not, however, obtain statistically significant results when evaluating changes in EEG-based measures from imaginary hand movements at group level. This may be influenced by limited and insufficient time spent training participants to use imagination to properly control their SMR activity. Participants were explicitly and repeatedly instructed to attempt actual hand movements in an unblinded effort to regain or relearn volitional movement of their hands. None-the-less, reasonably distributed spatial maps of EEG activity in the SMR frequencies of interest from motor imagery attempts were observed ([Figure 8](#F8){ref-type="fig"}). It is important, however, to note that motor imagery approaches are increasingly popular ([@B15]; [@B19]) and might be a relevant means of EEG-BCI translation, particularly in stroke patients with severely impaired motor function.

Limitations
-----------

These results suggest that EEG-BCI-FES has the potential to induce neuroplastic change and aid recovery of UE paresis. However, this analysis was constrained by sample size and heterogeneity in lesion location, level of impairment, and time since stroke. Greater power is needed to adequately generalize these results. Utilizing a larger and more homogeneous subject cohort could allow for more generalizable conclusions in future research. Further, 16 electrodes were used in EEG signal data acquisition and EEG were recorded only during the intervention phase and at no other time during the study. While there is no EEG data recorded in the control period to compare with the recordings during intervention, there are brain (EEG) -- behavior correlations specifically in EEG measures associated with motor function originating specifically from electrodes (C3/C4) ([Figure 3](#F3){ref-type="fig"}) overlying regions conventionally attributed to motor function. Scalp or surface level EEG recordings are understood to read the dipolar or regional sources assumed to represent the synchronous activity of hundreds of thousands of underlying neighboring neurons. It is therefore possible that even if stroke lesions damage traditional cortical areas associated with motor output (primary motor cortex), perilesional brain regions, as well as established functional areas (pre-motor area and supplementary motor areas) may contribute to ipsilesional signal recordings sufficient to drive successful classifier activation (i.e., brain signal oscillations 'discrete' enough for the BCI to interpret SMR change and execute the relevant device or output command -- in this case, horizontal cursor movement and facilitated FES activation) of a BCI.

### Spatial Coverage and Sampling

It is generally understood that using 16 electrodes is insufficient for source localization, especially given the limited spatial coverage and non-equidistant spacing of the electrodes in this cap array ([Figure 3](#F3){ref-type="fig"}) and thus, the present analysis does not consider such undertakings. In future research, the directionality and polarity of EEG-BCI-FES associated changes may lead to better understanding of the nature and sequence of motor related neuroplasticity as well as the neuroplastic influences of BCI technologies. Source reconstruction will be done once the sample size increases to sufficiently examine this aspect in a subset of stroke participants with homogeneity in lesion location. Given the heterogeneity of lesion location in the existing sample set, source localization might be premature.

#### Statistical approach

Such heterogeneity and restricted sample size similarly dissuaded the authors from attempting further conservative controls, such as multiple comparisons corrections. The authors conceived that further conservative data manipulations may wash out any potential ('trending to') significant relationships the authors or other groups may want to follow-up with future research. This manuscript, part of a larger on-going clinical trial, is an interim analysis which sought to elucidate any significant trends in the data as the study progressed so as to inform our future questioning of the data and to be better prepared to identify and test potentially significant interactions and factors in the larger post-stroke population.

#### Nature of the academic research environment

This is an on-going study in its seventh year of data acquisition and participant enrollment. Various project personnel have undergone and supervised the staffing, training, and data acquisition of this trial during its course. The authors work hard to best minimize differences in acquisition of study measures through extensive and repeated training of personnel.

Future Scope
------------

Despite the existing challenges to providing evidence-based treatment strategies in the stroke rehabilitation field, combined therapies may be used to achieve the maximal motor function recovery for participants ([@B38]). Development of effective strategies for rehabilitation of impaired motor functions in stroke patients, as well as for monitoring and evaluation of changes during an applied intervention is yet needed.

Conclusion
==========

EEG Conclusions
---------------

Non-invasive EEG-based measures of motor cortex function, such as r-squared (reflecting desynchronization levels of the relevant SMR rhythms), could provide an efficient means of tracking and even predicting functional changes in stroke patients during the course of the EEG-BCI-FES intervention. As ERD changes were reported at the group level, and given the heterogeneity in the sample, it may be argued that the reported changes not only suggest a change in function for the majority of participants (despite few changes attaining clinically significant differences) but also, given more selective sampling and independent variable control, an even more clinically relevant relationship between ERD and recovery may exist. Tracking SMR modulations may be a potential predictor of recovery or indicator of recovery potential in a patient.

BCI Conclusions
---------------

The observed effects to motor measures might also be a consequence of challenging and rewarding movements associated with (ADLs), which the participants previously may have thought to be impossible or too difficult to produce successfully. BCI intervention may help challenge a survivor's individual conception of their limitations by pushing a participant to use the affected hand and rewarding them (according to an anticipatable, clear, and consistent schedule) for doing so. This is to suggest that the minimal gains observed by most participants, in comparison to the significant gains obtained by some, and their absence in others, may be related to the encouragement of attempting previously ineffective motor behaviors. It is possible the statistically significant gains observed, supported by the higher incidence of significance in subjective measures than the number of lab-based objective measures, could be the result of the specific reward structure of the design in addition to, or more so than any reliable neuromechanical or electrophysiological contributions.

### Biological Limitations and Contribution of Learning Theories

If normal muscle synergies (e.g., the same muscles act to abduct one's arm each time, in a healthy adult) are disrupted by an insult such as stroke, robbing the motor circuity of its primary output components (e.g., central nervous system efference to peripheral nervous system effectors), residual functional capacities are limited by the ability of the system to retrain or re-map (link) the CNS commands to PNS effectors ([@B46]). Successful BCI intervention must connect the peripheral muscle activation with the muscle effectors necessary to execute a motor function according to the user's CNS command to do so. Unfortunately, retraining the processes of the descending motor system is not always an option as stroke often results in irreparable tissue damage or death to motor pathways and even their sensorimotor confederates. Post-stroke neuronal loss alters recruitment of downstream muscle synergies ([@B7]), and alters a synergy's internal structure ([@B50]) depending on stroke severity ([@B49]). One biological mechanism left to these survivors is to adapt existing synergistic capacities toward a compensatory strategy (e.g., recruitment of novel synergistic families to accomplish a familiar movement). Thus, future BCI methodologies should rely on classical conditioning and Hebbian learning theories as well as predictive modeling for developmental guides to practice. Future BCI designs may also benefit from classification of distal muscle capacities and synergistic integrities so as to better measure, represent, facilitate, or compensate for the functional consequences of the stroke disturbed CNS and PNS circuitry.

From previously published findings ([@B67],[@B68],[@B69]; [@B57]), we can comprehend that BCIs induce neuronal changes which, in turn, might help the participants challenge their paresis or perceived disabilities ([@B10]; [@B48]), as they access or develop (i.e., train) new functional aptitudes, or reinvigorate old synergies and neural networks dampened by insult ([@B48]). Participants may have the perception that their ability has improved or changed; however, when assessed by objective measures, those perceptions, at least here, are not always confirmed at equal magnitude. The authors posit that neural changes reported by other groups and in our previous publications may not always manifest as clinically significant objective changes in motor function ([@B63]) because there is either, or both a threshold effect, or a missing component to this type of intervention (such as sufficient dosing parameters, subject selection, etc.). This opinion is potentially fortified by these results which suggest more time in intervention is related to greater electrophysiological change. Electrophysiological changes are understood to be possible biological precursors to function network change and eventually, functional behavioral change ([@B14]). Other than the simple explanation that objective lab-based measures might not reliably capture UE impairment well in stroke survivors, perhaps, as a result of engaging with this BCI intervention, this discrepancy might also arise because participants are beginning to engage their environment with the distal musculature of the impaired hand in ways they had been previously averse (unwilling) or unable to.

### More Intervention

Losing strategies, more often than not, do not win (e.g., adaptive vs. maladaptive behaviors). Maladaptive associations may simply need more time to be pruned away and relevant adaptive associations strengthened by increased and more highly structured reinforcement ([@B14]; [@B63]). If one assumes such a threshold effect, the neural-remodeling realized in these participants may suggest that more intervention trials were needed to translate to clinically significant, not just relevant, changes in objective measures of function. Results suggest a relationship between more trials and greater outcome measure change, paralleling a concept associated with training, or learning a new motor skill: practice makes permanent. It may be that amount of intervention, or inadequate 'dosage' in this case, explains the weak translation of observed brain level changes into behavioral gains for this cohort. Little evidence has thus far been offered to suggest an optimal BCI regimen. Perhaps there is even an upper limit, or even some consequence of fatigue. It is therefore suggested that future research address these questions and aim to better understand dose-response relationships and independent variable (lesion location, lesion volume, time since stroke, comorbid impairments, etc.) contributions to predict recovery potential and more efficaciously prescribe BCI intervention as therapy. All BCI research would benefit by a concerted effort to identify a therapeutic index for various BCI interventions (regimens) as well as attempt to target ideal patient profiles for prescription of BCI intervention as a therapy.
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